6RX6
Trypanosoma brucei PTR1 (TbPTR1) in complex with inhibitor 4 (NMT-C0026)
6RX6 の概要
| エントリーDOI | 10.2210/pdb6rx6/pdb |
| 関連するPDBエントリー | 6RX0 6RX5 |
| 分子名称 | Pteridine reductase, NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, methyl 1-[4-[[2,4-bis(azanyl)pteridin-6-yl]methyl-(3-oxidanylpropyl)amino]phenyl]carbonylpiperidine-4-carboxylate, ... (5 entities in total) |
| 機能のキーワード | trypanosoma brucei, pteridine reductase, ptr1, tbptr1, pteridine based inhibitors, oxidoreductase |
| 由来する生物種 | Trypanosoma brucei brucei |
| タンパク質・核酸の鎖数 | 4 |
| 化学式量合計 | 127690.01 |
| 構造登録者 | |
| 主引用文献 | Pohner, I.,Quotadamo, A.,Panecka-Hofman, J.,Luciani, R.,Santucci, M.,Linciano, P.,Landi, G.,Di Pisa, F.,Dello Iacono, L.,Pozzi, C.,Mangani, S.,Gul, S.,Witt, G.,Ellinger, B.,Kuzikov, M.,Santarem, N.,Cordeiro-da-Silva, A.,Costi, M.P.,Venturelli, A.,Wade, R.C. Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1. J.Med.Chem., 65:9011-9033, 2022 Cited by PubMed Abstract: The optimization of compounds with multiple targets is a difficult multidimensional problem in the drug discovery cycle. Here, we present a systematic, multidisciplinary approach to the development of selective antiparasitic compounds. Computational fragment-based design of novel pteridine derivatives along with iterations of crystallographic structure determination allowed for the derivation of a structure-activity relationship for multitarget inhibition. The approach yielded compounds showing apparent picomolar inhibition of pteridine reductase 1 (PTR1), nanomolar inhibition of PTR1, and selective submicromolar inhibition of parasite dihydrofolate reductase (DHFR) versus human DHFR. Moreover, by combining design for polypharmacology with a property-based on-parasite optimization, we found three compounds that exhibited micromolar EC values against while retaining their target inhibition. Our results provide a basis for the further development of pteridine-based compounds, and we expect our multitarget approach to be generally applicable to the design and optimization of anti-infective agents. PubMed: 35675511DOI: 10.1021/acs.jmedchem.2c00232 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.11 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






